Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history

被引:55
作者
Buttin, BM
Powell, MA
Mutch, DG
Babb, SA
Huettner, PC
Edmonston, TB
Herzog, TJ
Rader, JS
Gibb, RK
Whelan, AJ
Goodfellow, PJ
机构
[1] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA
[5] Thomas Jefferson Univ, Dept Pathol, Philadelphia, PA 19107 USA
关键词
D O I
10.1086/421332
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Hereditary nonpolyposis colorectal cancer (HNPCC) is caused by inherited mutations in DNA mismatch-repair genes, most commonly MLH1 or MSH2. The role MSH6 plays in inherited cancer susceptibility is less well defined. The aim of this study was to investigate the penetrance and expressivity of MSH6 mutations in kindreds ascertained through endometrial cancer probands unselected for family history. Detailed pedigrees were constructed for six MSH6 mutation carriers. All reported cancers and precancers were confirmed, and tissues were obtained when available. Tumors were analyzed for microsatellite instability (MSI) and for expression of MSH2, MLH1, and MSH6. MSH6 mutation status was determined for 59 family members. Of these 59 individuals, 19 (32%) had confirmed cancers and precancers. There was an excess of mutation carriers among the 19 affected family members (11[58%] of 19) compared with those among the 40 unaffecteds (8[20%] of 40 P = .0065, odds ratio = 5.5, 95% CI = 1.66-18.19). In four of the seven tumors analyzed from mutation carriers other than the probands, MSI and/or MMR protein expression was consistent with the involvement of MSH6. Overall estimated penetrance of the MHS6 mutations was 57.7%. Of the tumors in mutation carriers, 78% were part of the extended HNPCC spectrum. This study demonstrates that MSH6 germline mutations are, indeed, associated with increased cancer risk and that the penetrance of mutations may be higher than appreciated elsewhere. A combination of MSI and immunohistochemistry analyses may be helpful in screening for MSH6 mutation carriers.
引用
收藏
页码:1262 / 1269
页数:8
相关论文
共 26 条
  • [1] CLUES TO THE PATHOGENESIS OF FAMILIAL COLORECTAL-CANCER
    AALTONEN, LA
    PELTOMAKI, P
    LEACH, FS
    SISTONEN, P
    PYLKKANEN, L
    MECKLIN, JP
    JARVINEN, H
    POWELL, SM
    JEN, J
    HAMILTON, SR
    PETERSEN, GM
    KINZLER, KW
    VOGELSTEIN, B
    DELACHAPELLE, A
    [J]. SCIENCE, 1993, 260 (5109) : 812 - 816
  • [2] hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6
    Acharya, S
    Wilson, T
    Gradia, S
    Kane, MF
    Guerrette, S
    Marsischky, GT
    Kolodner, R
    Fishel, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) : 13629 - 13634
  • [3] Molecular and clinical characteristics of MSH6 variants:: An analysis of 25 index carriers of a germline variant
    Berends, MJW
    Wu, Y
    Sijmons, RH
    Mensink, RGJ
    van der Sluis, T
    Hordijk-Hos, JM
    de Vries, EGE
    Hollema, H
    Karrenbeld, A
    Buys, CHCM
    van der Zee, AGJ
    Hofstra, RMW
    Kleibeuker, JH
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 70 (01) : 26 - 37
  • [4] Boland CR, 1998, CANCER RES, V58, P5248
  • [5] MUTATION IN THE DNA MISMATCH REPAIR GENE HOMOLOG HMLH1 IS ASSOCIATED WITH HEREDITARY NONPOLYPOSIS COLON-CANCER
    BRONNER, CE
    BAKER, SM
    MORRISON, PT
    WARREN, G
    SMITH, LG
    LESCOE, MK
    KANE, M
    EARABINO, C
    LIPFORD, J
    LINDBLOM, A
    TANNERGARD, P
    BOLLAG, RJ
    GODWIN, AR
    WARD, DC
    NORDENSKJOLD, M
    FISHEL, R
    KOLODNER, R
    LISKAY, RM
    [J]. NATURE, 1994, 368 (6468) : 258 - 261
  • [6] Increased risk for hereditary nonpolyposis colorectal cancer-associated synchronous and metachronous malignancies in patients with microsatellite instability-positive endometrial carcinoma lacking MLH1 promoter methylation
    Buttin, BA
    Powell, MA
    Mutch, DG
    Rader, JS
    Herzog, TJ
    Gibb, RK
    Huettner, P
    Edmonston, TB
    Goodfellow, PJ
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (02) : 481 - 490
  • [7] de Leeuw WJF, 2000, J PATHOL, V192, P328, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH701>3.0.CO
  • [8] 2-2
  • [9] Recurrent germline mutation in MSH2 arises frequently de novo
    Desai, DC
    Lockman, JC
    Chadwick, RB
    Gao, X
    Percesepe, A
    Evans, DGR
    Miyaki, M
    Yuen, ST
    Radice, P
    Maher, ER
    Wright, FA
    de la Chapelle, A
    [J]. JOURNAL OF MEDICAL GENETICS, 2000, 37 (09) : 646 - 652
  • [10] Mutation in the mismatch repair gene Msh6 causes cancer susceptibility
    Edelmann, W
    Yang, K
    Umar, A
    Heyer, J
    Lau, K
    Fan, KH
    Liedtke, W
    Cohen, PE
    Kane, MF
    Lipford, JR
    Yu, NJ
    Crouse, GF
    Pollard, JW
    Kunkel, T
    Lipkin, M
    Kolodner, R
    Kucherlapati, R
    [J]. CELL, 1997, 91 (04) : 467 - 477